RESP - Common cold, Influenza, Sinusitis, Pneumonia Flashcards

1
Q

Common cold

Definition
Modes of transmission
Incubation period
Period of infectivity

A

General features
 Acute self-limiting viral infection
 One of upper respiratory tract infections (URTIs)
 Usually last for 3 – 10 days in normal host but clinical illness may last up to 2 weeks

Modes of transmission
- Hand contact
* Direct contact via an infected person- Self-inoculation of one’s own conjunctiva or nasal mucosa after touching a person being contaminated with cold virus
* Indirect contact with a contaminated environmental surface
- Small particle droplet (Droplet transmission) from sneezing or coughing that remains airborne
- Large particle droplet (Droplet transmission) - Deposition of large particle droplets that are expelled during sneezing and land on nasal or conjunctival mucosa

Incubation period
- Most common cold virus = 24 – 72 hours

Period of infectivity
- Viral shedding peaks on third day after inoculation which coincides with peak in symptoms
- Low level of viral shedding may persist for up to 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common cold

Epidemiology
Etiology
Clinical sequalae

A

Seasonal patterns
* Rhinovirus infections in September (autumn months)
* Parainfluenza virus infection in October and November (autumn months)
* Coronavirus, influenza virus and respiratory syncytial virus infection in December to February (winter months)

Virolgy:
Immunity to virus
* Rhinovirus, influenza virus, adenovirus and enterovirus produce lasting immunity but immunity does little to prevent subsequent cold because there are too many serotypes
* Coronavirus, parainfluenza virus and respiratory syncytial virus does NOT even produce lasting immunity

Factors increasing susceptibility and severity of URTIs
* Underlying chronic illness
* Immunocompromised
* Malnutrition
* Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adenovirus infection

Specific complications

A

Clinical
- Respiratory infections = Pharyngitis/ Bronchiolitis/ Pneumonia
- Ocular infections = Conjunctivitis (self-limiting and requires no specific treatment) or Keratoconjunctivitis (more severe and sight-threatening form of adenovirus infection)
- GI infections = Gastroenteritis
- GU infections = Hemorrhagic cystitis (Presents with hematuria, dysuria, frequency and urgency but with negative urine bacterial culture results which resolves on its own within 1 – 2 weeks, Urinalysis shows RBC and sterile pyuria

Other complications include myocarditis, meningoencephalitis and hepatitis

Biochemical
- Leukocytosis with neutrophilia

Radiological
- Manifests as features more typical of bacterial disease including high fever, lobar infiltrates and parapneumonic effusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Common cold

Pathogenesis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common cold

Clinical presentation
Complications

A

Complications of common cold
 Acute rhinosinusitis
 Acute otitis media
 Acute exacerbation of asthma
 Lower respiratory tract disease (LRTI): Bronchitis, Acute bronchiolitis, Pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Common cold

URT and lRT infection S/S
Ddx Common cold

A

Physical examination
General examination
* Conjunctival injection
* Nasal mucosal swelling
* Nasal congestion
* Pharyngeal erythema
* Lymphadenopathy

Respiratory examination
* Usually unremarkable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Common cold

Ix
Tx

A

Ix:
- CXR NOT routinely indicated; Indicated is physical examination suggests signs of consolidation or other parenchymal disease
- Sinus X-ray: Indicated if suspect secondary sinusitis
- Nasopharyngeal aspirate/ Throat swab for culture: Cost-ineffective, impractical and unnecessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Influenza

Clinical course
Types of influenza
Types of influenza virus

A

General features
 Self-limiting and usually recovers in 2 – 7 days
 Typical incubation period = 1 – 4 days
 Transmission: Droplet transmission

Terminology
- Seasonal influenza (e.g. H1N1/ H3N2): Common respiratory tract infection caused by human seasonal influenza viruses; Circulate in human population and cause widespread illnesses during each influenza season
- Avian influenza (e.g. H5N1/ H7N9/ H9N2): Influenza viruses that mainly affect birds and poultry; infected through direct contact with infected birds and poultry, their droppings and contaminated environment
- Influenza pandemic (e.g. H1N1/ H2N2/ H3N2): Caused by emergence and global spread of a new influenza virus originated from an animal influenza virus such as avian influenza virus; Virus undergoes major genetic changes resulting in efficient human-to-human transmission

Types of influenza virus
- Influenza virus A: May lead to pandemics; Divided into 18H (H1 – 18) and 11N (N1 – 11) subtypes
- Influenza virus B: Do NOT lead to pandemics
- Influenza virus C: Do NOT lead to pandemics; Do not become ill with mild symptoms in general

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Influenza virus

Epidemiology
Pathogenesis of new strains

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Influenza virus

Clinical presentation

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Influenza virus

Investigations

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Influenza virus

Indications of treatment/ high risk patient groups

A

Nature of the disease
* Viral infection but not bacteria but therefore antibiotics has NO role
* Self-limiting disease with low morbidity and mortality

Treatment
* Treatment is mainly supportive including antipyretics to relieve discomfort, adequate hydration, respiratory support and treatment of complications
* Counselling on Tamiflu (see below)
* Advice on seasonal influenza vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Influenza virus

Treatment options
Time course
Complications

A

Time course
- Antiviral is most likely to provide benefit when initiated within first 48 hours of illness

Indications:
- Individuals without higher risk conditions do NOT require testing or treatment; Individual present ≤ 48 hours can still be prescribed with antiviral to reduce the duration of illness by 1 day
- Individuals with high risk conditions or severe hospitalized (complicated) cases should receive antiviral treatment even > 48 hours after the onset of symptoms

Effectiveness
- Shorten duration of influenza symptoms by 1 day
- Reduce influenza complications
- Reduce duration of viral shedding

Dosing:
- For treatment = BD for 5 days (MUST complete full-course despite clinical improvement)
- For prevention = Once daily for 10 days

Adverse effects
- MOST common = Nausea and vomiting (15%)/ Headache
- MOST serious = Neuropsychiatric effects (Delirium/ Hallucinations/ Confusion/ Abnormal behaviors/ Convulsion/ Self-injury/ Suicidal ideation)
- Severe skin reactions (SJS/ Toxic epidermal necrolysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Influenza virus

Complications

A

Pneumonia (most common)
- Primary viral pneumonia: Bilateral reticular or reticulonodular opacities with or without superimposed consolidation on CXR
- Secondary bacterial pneumonia

Myositis and rhabdomyolysis
- Influenza B virus is well-known to cause acute myositis
- marked by muscle pain and weakness particularly in calf muscles and myoglobinuria
- ↑ Serum creatine phosphokinase (CK)

CNS infections
- Aseptic meningitis
- Encephalitis
- Reye’s syndrome: Rapidly progressive encephalopathy with hepatic dysfunction, characterized by vomiting and confusion which rapidly evolves into seizure and coma and hepatomegaly; associated with aspirin use
- Transverse myelitis
- Guillain-Barre syndrome (GBS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Influenza virus

Vaccine type
High risk groups for vaccination
Contraindications to vaccination

A

Vaccine type:
- Only inactivated seasonal influenza vaccine is currently registered in HK
- Trivalent and quadrivalent inactivated influenza vaccines are recommended for use
- Requires about 2 weeks after vaccination for antibodies to develop and provide protection against influenza virus infection

Indications/ High priority groups
- Persons aged ≥ 50
- Children between age 6 months – 11 years
- Pregnant woman (only use inactivated seasonal vaccine, not live attentuated vaccines)
- Elderly living in residential care homes
- Long-stay residents of institutions for persons with disability
- Healthcare workers
- Poultry workers
- Pig farmers and pig-slaughtering industry personnel
- Chronic medical problems: CVS, Lung, Liver, Kidney, CNS, functional impairment and aspiration, immunocompromised states, children/ adolescent on long term aspirin therapy, prior pneumococcal diseases, prior cochlear implants, surgical history of CSF leak

Contraindications
- Allergy to previous dose of inactivated influenza vaccine or other vaccine components
- Allergy to egg if severe or history of anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Influenza virus

Drople precautions

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sinusitis

Definition
Classification

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sinusitis

Epidemiology

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sinusitis

Risk factors
Microbiology

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Sinusitis

Anatomy of sinuses
Course, drainage, blood and nerve supply of each sinus

A
21
Q

Sinusitis

Pathogenesis
Clinical features

A

Pathogenesis
1. Acute bacterial rhinosinusitis:
- Occurs most commonly as a complication of viral infection
- can also be associated with rhinitis or conditions that obstruct the nose or impair local or systemic immune function

  1. Acute viral rhinosinusitis
    - Begins with viral inoculation via direct contact with conjunctiva or nasal mucosa
    - Viral rhinitis spreads to paranasal sinus during nose blowing
    - Inflammation occurs resulting in sinonasal hypersecretion and increased vascular permeability, mucosal edema, copious thickened secretions and impaired mucociliary clearance
22
Q

Sinusitis

Diagnostic criteria
Ix

A

Diagnostic criteria
Acute bacterial rhinosinusitis
- Persistent symptoms or signs of ARS lasting ≥ 10 days without evidence of clinical improvement (OR)
- Onset of severe symptoms or signs of high fever and purulent nasal discharge or facial pain for at least 3 – 4 consecutive days at the beginning of illness (OR)
- Symptoms of a typical viral URTI that are slowly improving but worsen again with more severe symptoms and signs after 5 – 6 days

Acute viral rhinosinusitis
- Symptoms or signs of ARS < 10 days that are not worsening

Investigations:
- Anterior rhinoscopy
* Diffuse mucosal edema
* Narrowing of middle meatus
* Inferior turbinate hypertrophy
* Copious and purulent discharge

  • Otoscopy
  • Indicated in patients with symptoms of ear pain, fullness or pressure, hearing loss or tinnitus
  • Biochemical tests: Sinus aspirate or endoscopic culture of middle meatus; indicated on suspicion of intracranial extension of infection or other serious complication

Imaging:
- X-ray sinus: sinus fluid levels, poor visualization of ethmoid sinuses
- CT sinus: air-fluid levels, mucosal edema and thickening, air bubbles within sinuses and opacification, e air-fluid levels, mucosal edema and thickening, air bubbles within sinuses and opacification
- MRI sinus: delineate extent of soft tissue involvement

23
Q

Sinusitis

Treatment options

A

Medical:
- 1st line antibiotics: Augmentin/ Cefuroxime
- 2nd line antibiotics: Doxycycline/ Levofloxacin
- Glucocorticoids: Intranasal spray
- Analgesics: Paracetamol or NSAIDs
- Decongestants: For eustachian tube dysfunction

Surgical:
- Saline irrigation for pain relief

24
Q

Sinusitis

Complications

A

Complications of acute rhinosinusitis
- Orbital and periorbital cellulitis
* Presents with ocular pain, eyelid swelling and erythema
* Orbital cellulitis will cause swelling and inflammation of extraocular muscles and fatty tissues within the orbit
* Leads to pain with eye movements, proptosis, ophthalmoplegia and diplopia

  • Meningitis
  • Brain abscess
  • Epidural abscess
  • Osteomyelitis of sinus bone: Presents with gradual onset of dull pain at involved site with or without movement
  • Septic cavernous sinus thrombosis: Presents with cranial nerve palsies and headache
25
Q

Pneumonia

Definition
Routes of infection

A
26
Q

Pneumonia

Classifications

A
27
Q

Pneumonia

Patterns of bacterial and viral pneumonia

A
28
Q

Pneumonia

Risk factors

A
29
Q

Pneumonia

Causative pathogens in adults

A

Typical organisms include S. pneumoniae, H. influenzae, S. aureus, S. pyogenes, aerobic Gram -ve bacteria and anaerobes

Atypical organisms include Chlamydia pneumoniae, Chlamydophila psittaci, Mycoplasma pneumoniae and Legionella pneumophila

MDR pathogens
o MRSA
o ESBL-producing Enterobacteriaceae
o Pseudomonas aeruginosa
o Acinetobacter sp.

30
Q

Pneumonia

Causative pathogens in children

A
31
Q

Features of atypical pneumonia

A
32
Q

Recurrent pneumonia in children

Definition
Associated conditions

A
33
Q

Atypical pnuemonia

Legionella pneumophila presentation, transmission
Pseudomonas aeruginosa risk factros

A

Legionella pneumophila:
- Legionnaires’ disease is one form of Legionellosis in which patients present with prominent gastrointestinal and CNS symptoms
- Associated with exposure to a variety of aerosol-producing devices
o Legionella grows well in warm water (25 – 40o C) and aqueous environment
o Includes showers, water tanks, water fountains, whirlpool and spas, grocery store mist machine and cooling towers of air conditioning systems

Pseudomonas aeruginosa: risk factors
- Risk factors include bronchiectasis, repeated use of antibiotic course or corticosteroids, structural lung abnormalities including COPD, immunocompromised state including neutropenia, HIV infection, solid organ or stem cell transplantation

34
Q

Pneumonia

Clinical stages

A
35
Q

Pneumonia

Clinical presentation (adult)

A
36
Q

Pneumonia

Clinical presentation (children)

A
37
Q

Pneumonia

History taking questions

A
38
Q

Pneumonia

Clinical features

A
39
Q

Pneumonia

Biochemical investigations

A
40
Q

Pneumonia

Radiological investigations

A
41
Q

Pneumonia

Treatment options

A

General:
- O2 supplementation/ mechanical ventilation for respiratory failure
- Fluid rehydration
- Chest physiotherapy
- Treatment of uderlying diseases e.g. COPD

42
Q

Pneumonia

Choice of Abx for pregnancy/ paediatrics

A

Choice of antibiotic in pregnancy and infants

  • β-lactams and macrolides are safe in pregnancy
  • Tetracycline is avoided in pregnant woman and children age < 8 as it can cross placenta and cause accumulation in fetal bone and teeth (enamel staining)
  • Fluoroquinolones is avoided in pregnant woman and children age < 18 as it causes development of arthropathy with erosions to the cartilage in weight-bearing joints in
    experimental animal studies
43
Q

Pneumococcal pneumoniae

Antibiotics of choice
Mechanism of resistance

A
44
Q

Pneumonia + Penicillin allergy

Antibiotics of choice

A
45
Q

Mycoplasma pneumonia

Choice of antibiotics

A

Management of Mycoplasma infection
* Tetracycline is generally avoided in pregnant woman and children age < 8 as it can cross placenta and cause accumulation in fetal bone and teeth (enamel staining)

  • Fluoroquinolones is generally avoided in pregnant woman and children age < 18 as it causes development of arthropathy with erosions to the cartilage in weight-bearing joints in experimental animal studies
  • Macrolide is the choice of antibiotics in children for Mycoplasma pneumonia but it is associated with a high rate of resistance in Asia (40%)
  • Choices of antibiotics in macrolide-resistant pneumonia (patient not responding after 48 hours without resolution of fever)
  • < 8 years old: Fluoroquinolones
  • ≥ 8 years old: Doxycycline
46
Q

Pneumonia

Prognostic scoring

A
47
Q

Pneumonia

Complications

A
48
Q

Pneumonia

Prevention

A